Kalaris to Present at Clinical Trials at the Summit 2026

Go back to Kalaris to Present at Clinical Trials at the Summit 2026
(NASDAQ: KLRS) Delayed: 4.15 +0.03 (0.73%)
Previous Close $4.12    52 Week High
Open $4.10    52 Week Low
Day High $4.31    P/E N/A 
Day Low $3.99    EPS
Volume 81,244